CVS has been reviewing its strategic options for months, including a potential breakup, according to a person familiar with the talks, as rising medical costs in its Aetna insurance arm weigh on the health-care conglomerate.
The entrance of hedge fund Glenview Capital Management, which approached the company a few weeks ago about improving the business, made the conversation public and ratcheted up pressure on CEO Karen Lynch.
